JP Morgan sees strong growth for Ascentage Pharma, citing its late-stage cancer drugs. The biotech's 2024 sales surged 342% ...

CNW/ - Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for ...

Walgreen Co., Kroger Co., and Albertsons Cos. Inc. accused two pharmaceutical companies Tuesday of conspiring to delay the generic version of a drug to treat gastroesophageal reflux disease and ...

Harmony Biosciences has named Adam Zaeske its next chief commercial officer, luring the Takeda veteran back from Europe to ...

Envestnet Portfolio Solutions Inc. reduced its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by ...

Canada announced that Health Canada has expanded the marketing authorization for HyQvia for chronic inflammatory demyelinating ...

Revenue in 2024 increased 342%year-over-year to US$134.3 million (RMB980.7 million), attributable in part to Takeda’s option payment and strong ...

Trump also nominated Republican attorney Thomas March Bell to lead the Department of Health and Human Service’s Office of Inspector General. Calley Means, a chronic disease entrepreneur and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Rusfertide is being jointly developed with Takeda Pharmaceuticals and is moving towards an NDA filing with the FDA this year. Icotrokinra (JNJ-2113), the first-ever oral IL-23 receptor antagonist ...